The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA. (Q40643235)

22 September 2017

The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA. (English)

1 reference

22 September 2017

1 reference

1 reference

Sifang Zhou

1

1 reference

22 September 2017

Rong Liu

2

1 reference

22 September 2017

Bahige M Baroudy

3

1 reference

22 September 2017

Bruce A Malcolm

4

1 reference

22 September 2017

Gregory R Reyes

5

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

22 September 2017

1 reference

22 September 2017

310

1 reference

22 September 2017

333-342

1 reference

22 September 2017

2

1 reference

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Efficient initiation of HCV RNA replication in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Mechanism of La Crosse virus inhibition by ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Hepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

RNA virus error catastrophe: direct molecular test by using ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Viruses at the edge of adaptation.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Selforganization of matter and the evolution of biological macromolecules

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Ribavirin Induces Error-Prone Replication of GB Virus B in Primary Tamarin Hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Lethal mutagenesis of HIV with mutagenic nucleoside analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Inhibitors of IMP dehydrogenase prevent sindbis virus replication and reduce GTP levels in Aedes albopictus cells

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Efficient Virus Extinction by Combinations of a Mutagen and Antiviral Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Characterization of cell lines carrying self-replicating hepatitis C virus RNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Pharmacokinetics and absolute bioavailability of ribavirin in healthy volunteers as determined by stable-isotope methodology.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Studies on the mechanism of the antiviral activity of ribavirin against reovirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Response of foot-and-mouth disease virus to increased mutagenesis: influence of viral load and fitness in loss of infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Effect of phosphorylated ribavirin on vesicular stomatitis virus transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Epidemiology of hepatitis C: geographic differences and temporal trends

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Mode of action of ribavirin: effect of nucleotide pool alterations on influenza virus ribonucleoprotein synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

Mutation Frequencies at Defined Single Codon Sites in Vesicular Stomatitis Virus and Poliovirus Can Be Increased Only Slightly by Chemical Mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900152-1

7 January 2021

10.1016/S0042-6822(03)00152-1

Identifiers

DOI

1 reference

22 September 2017

1 reference